Choksi Laboratories (BOM:526546) Current Ratio: 0.82 (As of Mar. 2026) — 10% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526546 Choksi Laboratories Ltd BOM:526546
57 GF Score
Price ₹118.20
GF Value ₹97.92
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Choksi Laboratories Current Ratio?

Choksi Laboratories BOM:526546 57 Current Ratio is 0.82 as of Mar. 2026, which is 10% below its 10-year median of 0.91. GuruFocus rates BOM:526546 with a GF Score™ of 57/100 and a GF Value™ of ₹97.92 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, Choksi Laboratories ranks worse than 83.96% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Choksi Laboratories's current ratio for the quarter that ended in Mar. 2026 was 0.82.

Choksi Laboratories has a current ratio of 0.82. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Choksi Laboratories has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for Choksi Laboratories's Current Ratio or its related term are showing as below:

BOM:526546' s Current Ratio Range Over the Past 10 Years
Min: 0.68   Med: 0.91   Max: 1.21
Current: 0.82

During the past 13 years, Choksi Laboratories's highest Current Ratio was 1.21. The lowest was 0.68. And the median was 0.91.

BOM:526546's Current Ratio is ranked worse than
83.96% of 212 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.11 vs BOM:526546: 0.82

Choksi Laboratories  (BOM:526546) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Choksi Laboratories Current Ratio Related Terms


Choksi Laboratories Current Ratio Historical Data

* Premium members only.

The historical data trend for Choksi Laboratories's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Choksi Laboratories Current Ratio Chart

Choksi Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 1.11 0.77 0.68 0.82

Choksi Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.00 0.74 0.00 0.82

BOM:526546 vs TMO, DHR, IDXX: Current Ratio Comparison

For the Diagnostics & Research subindustry, Choksi Laboratories's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Choksi Laboratories Current Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Choksi Laboratories's Current Ratio distribution charts can be found below:

* The bar in red indicates where Choksi Laboratories's Current Ratio falls into.


BOM:526546
57GF Score
Choksi Laboratories Ltd BOM:526546
Current Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Choksi Laboratories Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Choksi Laboratories's Current Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Current Ratio (A: Mar. 2026 )=Total Current Assets (A: Mar. 2026 )/Total Current Liabilities (A: Mar. 2026 )
=188.667/230.876
=0.82

Choksi Laboratories's Current Ratio for the quarter that ended in Mar. 2026 is calculated as

Current Ratio (Q: Mar. 2026 )=Total Current Assets (Q: Mar. 2026 )/Total Current Liabilities (Q: Mar. 2026 )
=188.667/230.876
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 0.82 mean?
Choksi Laboratories (BOM:526546) has a Current Ratio of 0.82 as of Mar. 2026. This is 10% below median its historical median of 0.91. Over the past decade, Choksi Laboratories' Current Ratio has ranged from 0.68 to 1.21. According to the industry distribution chart, Choksi Laboratories ranks #178 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 84%.
Is Choksi Laboratories' Current Ratio too high?
Choksi Laboratories' current Current Ratio of 0.82 is 10% below median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.68 to a high of 1.21. The Medical Diagnostics & Research industry median Current Ratio is 2.11. Choksi Laboratories' value of 0.82 is 61.1% below this industry median. Based on the distribution chart, Choksi Laboratories ranks #178 out of 212 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Choksi Laboratories has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Choksi Laboratories' Current Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Choksi Laboratories ranks #178 out of 212 companies for Current Ratio. This places Choksi Laboratories in the lower half of its industry. The industry median Current Ratio is 2.11. Choksi Laboratories' value of 0.82 is 61.1% below this benchmark. Historically, Choksi Laboratories' own Current Ratio has ranged from 0.68 to 1.21 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 2.11, Choksi Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 2.11, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Choksi Laboratories's current Current Ratio of 0.82 is 61.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Choksi Laboratories's current Current Ratio is 0.82, which is 10% below median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Choksi Laboratories (BOM:526546) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹97.92, compared to a current price of ₹118.20 — trading 20.7% above its estimated fair value. The current Current Ratio is 0.82, which is 10% below median its 10-year median of 0.91 and 61.1% below the Medical Diagnostics & Research industry median of 2.11. Choksi Laboratories' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Choksi Laboratories (BOM:526546), the current Current Ratio is 0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Choksi Laboratories (BOM:526546) Overvalued in 2026?

Based on GuruFocus' analysis, Choksi Laboratories stock appears to be overvalued. The current stock price of ₹118.20 is trading 20.7% above its estimated GF Value™ of ₹97.92. GuruFocus considers Choksi Laboratories to be Modestly Overvalued.

Key valuation signals for BOM:526546:

  • Current Ratio: 0.82 (10% below median its 10-year median of 0.91)
  • GF Value™: ₹97.92 vs. price of ₹118.20 (20.7% above fair value)
  • GF Score™: 57/100 with 5 warning signs
  • Industry Position: 61.1% below the Medical Diagnostics & Research median (#178 of 212)

No single metric tells the full story. See the BOM:526546 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Choksi Laboratories Business Description

Address Survey no. 9/1, Near Tulsiyana Industrial Park, Gram Kumerdi, Indore, MP, IND, 452010
Choksi Laboratories Ltd is an analysis and research company. The company provides contract testing and analytical services. The Company analyzes for its clients as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.
57GF Score

Get the complete analysis for BOM:526546

Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹118.20
Price
₹97.92
GF Value